What's next? : It's been quite a... - Advanced Prostate...

Advanced Prostate Cancer

20,967 members26,122 posts

What's next?

Curehunter profile image
10 Replies

It's been quite a journey since my DX in Feb 2020. ADT just worked for 3 months before becoming CR. Zytiga did not work for me at all. Found to be BRAC2 so on Parp Inhibitor since late November (Triton3 trial). Last PSA reading was 0.38 (rise from 0.23 previous month). I know it's the trend that's important rather than a one off increase.

I'm looking to get a full molecular analysis done. What markers should they be looking for (other than the usual MSI, PD-1, PD-L1). If no other actionable mutations then what treatment (or clinical trials) should I consider next (chemo, Lu-177)?

Many thanks for any suggestions.

Best wishes.

Written by
Curehunter profile image
Curehunter
To view profiles and participate in discussions please or .
Read more about...
10 Replies
lewicki profile image
lewicki

Can you find a LU-177 trial? In the US they are doing direct in California without a trial. Travel?

Curehunter profile image
Curehunter in reply to lewicki

Thanks. Will first look for trials here in the UK, but am open to travelling if required.

Tall_Allen profile image
Tall_Allen in reply to lewicki

No they are not.

Curehunter profile image
Curehunter

Thanks. I know my consultant will propose chemo.

Rahul_Patel profile image
Rahul_Patel

How many cycles you completed?

Tall_Allen profile image
Tall_Allen

It may be more useful to have cell histology and IHC than genomics. The genomics are pretty standard. Those companies look for mutations, expression or loss of specific genes known to be associated with PC.

When PARP inhibitors work, the combination of a taxane + a platin also works.

You should also look at the various Xofigo combination trials:

prostatecancer.news/2021/02...

Curehunter profile image
Curehunter in reply to Tall_Allen

Thank you, I'll discuss these at my next appointment.

ellie2211 profile image
ellie2211 in reply to Tall_Allen

Could xofigo be used by someone with osteoporosis? ( With xgeva) this is a treatment we are considering at the moment but are afraid of bone marrow/bone issues.... The option is xofigo or jevtana

Tall_Allen profile image
Tall_Allen in reply to ellie2211

Yes, with Xgeva. In the link above there is a trial where Xofigo was combined with docetaxel at a reduced dose.

MateoBeach profile image
MateoBeach

I would want to start bone strengthening/ protecting right away with Xgeva (or Zometa). And ask for Provenge immunotherapy now. Get it on your side as earlier is better. Xofigo to treat the bone Mets also without delay as it also works better before smaller Mets grow. And you should discuss combining chemo with the Xofigo per T_A’s article. The lower dose docetaxel (60mg/M^2) and possibly with carboplatin look good. If they won’t agree to give it simultaneously per trial protocols, then in sequence after the Xofigo series is done. Or vice-versa.

Not the time to hold back, Hunter. Aim and fire. Talk these options through with the best oncologists available to you. Paul

You may also like...

Off Xtandi, what next?

Xtandi worked much anyway. My PSA did not rise but never really dropped much and so maybe the...

Failing Lupron? What's next?

Will we continue to monitor the PSA since the rise is not doubling? Should we expect another scan?...

Chemo failure. What next?

Not recovering well. My PSA on diagnosis was 821. It is now down to 3.1. Since diagnosis last...

Casodex failure? What's next?

for good, but now it’s creeping up again. Other than some slight neutropenia, he has felt great...

Enzalutamide resistance. What's next?

some resistance to it. The last three PSA tests have shown a rise. What options do we have next?...